France Hospital Acquired Infection (HAI) control Market Market Report 2023 to 2030

France Hospital Acquired Infection (HAI) control Market Analysis

$ 3999

France Hospital Acquired Infection (HAI) Control Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Hospital Acquired Infection (HAI) Control is expanding as a result of rising population of elderly along with chronic diseases and growing prevalence of hospital acquired infections. This demand is fueling the development of better control methods for the hospital acquired infections. Some of the key players in the global Hospital Acquired Infection (HAI) Control Market include 3M Company, STERIS plc, Getinge AB, Advanced Sterilization Products, Ecolab Inc., MATACHANA GROUP, Belimed AG, Reckitt Benkiser, Contec Inc., Miele Group, and MMM Group.

ID: IN10FRHS060 CATEGORY: Healthcare Services GEOGRAPHY: France AUTHOR: Aneri Parekh

Buy Now

France Hospital Acquired Infection (HAI) control Market Executive Summary

France Hospital Acquired Infection (HAI) control Market is valued at around $166.4 Bn in 2022 and is projected to reach $226 Bn by 2030, exhibiting a CAGR of 3.9% during the forecast period 2023-2030.

Pathogens, which spread swiftly in the body, are typically to blame for hospital-acquired infections. Infections spread more quickly than chronic infections in hospitals because of the sick individuals' weakened immune systems and the unsanitary surroundings. Numerous patients worldwide are affected by nosocomial infections, which considerably increase mortality rates and financial losses. According to World Health Organization, approximately 15% of hospitalised patients acquire hospital-acquired infections. This boosts the growth of the market for Hospital Acquired Infection (HAI) Control.

The increasing frequency of chronic diseases, the rising number of surgical procedures, and the rising incidence of hospital-acquired infections are predicted to propel the segment's expansion. Surface disinfectants are essential in preventing these illnesses, which will accelerate the market’s growth in future.

Firms 3M Company, STERIS plc, Getinge AB, Advanced Sterilization Products, Ecolab Inc., MATACHANA GROUP, Belimed AG, Reckitt Benkiser, Contec Inc., Miele Group, and MMM Group, are some of the major players in the Hospital Acquired Infection (HAI) Control Market.

The number of surgical operations carried out globally has significantly increased over time. Around 235 Mn major surgical procedures are carried out annually worldwide, according to the World Health Organization (2019). This is explained by the rising incidence of spinal injuries and sports-related injuries, as well as the rising prevalence of obesity and other lifestyle illnesses. The demand for various surgical equipment and medical devices has increased as a result of the rising number of surgical procedures done. Due to the benefits of sterilised items that have been proved over time, as well as the rising knowledge of their efficacy in healthcare settings, this is anticipated to increase demand for Hospital Acquired Infection Control market.

The market for Hospital Acquired Infection Control is anticipated to grow as a result of increased demand for sterilisation and disinfection in hospitals and clinics, technological advancements in sterilisation & disinfection equipment, the surge in hospital outsourcing of sterilisation services, pharmaceutical & medical device companies, increased in production of medical nonwovens & single-use products, and more. But Hospital Acquired Infection Control market expansion is anticipated to be constrained by the negative impacts of chemical disinfectants and worries about the safety of reprocessed instruments.

Market Dynamics

Drivers of France Hospital Acquired Infection (HAI) Control Market:

Increasing Incidence and Prevalence Hospital Acquired Infections: The incidence of infections acquired in hospitals is rising as a result of a lack of preventive measures. The contaminated medical devices and equipment frequently cause illnesses in hospitals and will increase demand for Hospital Acquired Infection Control.

Growing Number of Surgical Procedures: The number of surgical procedures carried out globally has significantly increased over time as a result of lifestyle diseases, an ageing population, and an increase in spinal injuries, which are the main factors boosting market growth for Hospital Acquired Infection Control.

Rising Number of Geriatric Population: As the world's population ages, chronic conditions including cardiovascular disease, cancer, diabetes, and other autoimmune disorders become more prevalent, and the market for Hospital Acquired Infection Control is expected to expand at a faster rate.

Developments in Hospital Acquired Infection (HAI) Control Market:

In 2022, Sonoma Pharmaceuticals, Inc. and the MicroSafe Group DMCC reported that Nanocyn hospital-grade disinfectant has been added to the list of COVID-19 disinfectants maintained by the United States Environmental Protection Agency’s List N.

In 2022, PDI launched Sani-24 Germicidal Disposable Wipe, Sani-HyPerCide Germicidal Disposable Wipe, and Sani-HyPerCide Germicidal Spray, innovative disinfectants to help infection prevention professionals in the fight against rising healthcare-associated infections (HAIs).

Key players

Anios (a part of Ecolab Inc.) GAMA Healthcare Ltd. Laboratoires Anios Sebia Group Medline Industries, Inc. 3M Company Sch?lke & Mayr GmbH Steris Corporation Ethicon, Inc. (a subsidiary of Johnson & Johnson) Synergy Health plc

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For France Hospital Acquired Infection (HAI) Control Market

By Product:

Sterilizers
Disinfectors
Endoscope Reprocessors
Microbial Testing Instruments
Reagents
Consumables
Disinfectants
Infection Prevention and Surveillance Software
Others

By Application:

Brain Imaging
Disease Testing
Drug-Resistance Testing

By Technology:

Phenotypic Methods
Genotypic Methods

By Disease:

Hospital Acquired Pneumonia
Bloodstream Infection
Surgical Site Infection
Gastrointestinal Infection
Urinary Tract Infection
Others

By End-user:

Hospitals
ICUs
Ambulatory Surgical
Diagnostic Centers
Nursing Homes
Maternity Centers
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.